Cargando…
Willingness to obtain COVID-19 vaccination in adults with multiple sclerosis in the United States
Background: As vaccines for the coronavirus become available, it will be important to know the rate of COVID-19 vaccine acceptability in adults with multiple sclerosis (MS), given that vaccination will be a key strategy for preventing SARS-CoV-2 infections. Using a national sample of adults with MS...
Autores principales: | Ehde, Dawn M., Roberts, Michelle K., Herring, Tracy E., Alschuler, Kevin N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7825851/ https://www.ncbi.nlm.nih.gov/pubmed/33508570 http://dx.doi.org/10.1016/j.msard.2021.102788 |
Ejemplares similares
-
COVID-19 vaccine hesitancy in adults with multiple sclerosis in the United States: A follow up survey during the initial vaccine rollout in 2021
por: Ehde, Dawn M., et al.
Publicado: (2021) -
Distress and risk perception in people living with multiple sclerosis during the early phase of the COVID-19 pandemic
por: Alschuler, Kevin N., et al.
Publicado: (2021) -
Characterizing chronic pain phenotypes in multiple sclerosis: a nationwide survey study
por: Kratz, Anna L., et al.
Publicado: (2021) -
Mindfulness-based cognitive therapy and cognitive behavioral therapy for chronic pain in multiple sclerosis: a randomized controlled trial protocol
por: Ehde, Dawn M., et al.
Publicado: (2019) -
Health Behaviors, Wellness, and Multiple Sclerosis Amid COVID-19
por: Motl, Robert, et al.
Publicado: (2020)